Timber Hill’s VanEck Biotech ETF BBH Stock Holding History

Timber Hill’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,169	Closed	-$973K	–	1012
2017 Q1	$973K	Buy	8,169 +1,529	+23%	+$179K	0.01%	1088
2016 Q4	$714K	Sell	6,640 -20,720	-76%	-$2.25M	﹤0.01%	1462
2016 Q3	$3.15M	Buy	27,360 +3,964	+17%	+$452K	0.02%	631
2016 Q2	$2.39M	Buy	23,396 +17,986	+332%	+$1.92M	0.01%	815
2016 Q1	$561K	Buy	5,410 +3,086	+133%	+$322K	﹤0.01%	1517
2015 Q4	$295K	Sell	2,324 -418	-15%	-$51.2K	﹤0.01%	1929
2015 Q3	$313K	Buy	+2,742	New	+$363K	﹤0.01%	2021
2015 Q2	–	Sell	-2,003	Closed	-$260K	–	2463
2015 Q1	$260K	Buy	+2,003	New	+$252K	﹤0.01%	2103

Other funds holding BBH

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return

Timber Hill's BBH Position: Q2 2017 in Review

Timber Hill sold out of VanEck Biotech ETF (BBH) in Q2 2017, closing a stake of 8,169 shares — an estimated $973K sold.

Timber Hill first reported a position in BBH in Q1 2015 and held it in 8 quarters. The position peaked at $3.15M in Q3 2016. 83 funds tracked by Wall St. Rank hold BBH as of Q2 2017.

Timber Hill reported no remaining VanEck Biotech ETF position as of Q2 2017 after selling out during the quarter.
Timber Hill sold 8,169 VanEck Biotech ETF shares in Q2 2017, an estimated $973K.
Timber Hill first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 8 quarters.
Timber Hill's VanEck Biotech ETF position peaked at $3.15M in Q3 2016.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.